Skip to content

Comparison of Remimazolam and Sevoflurane for General Anesthesia in Pediatric Patients

Comparison of Remimazolam and Sevoflurane for General Anesthesia in Pediatric Patients

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs051250146
Enrollment
14
Registered
2025-10-29
Start date
2025-10-29
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pediatric patients undergoing surgery under general anesthesia general anesthesia

Interventions

Sponsors

Kimura Satoshi
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - 2-7 yo - Patients undergoing surgery under general anesthesia - Written consent obtained from the legal guardians or minors' caregivers regarding participation in the study

Exclusion criteria

Exclusion criteria: - Patients eligible for this study from the second occurrence during the study period - Patients with neurological disorders, cardiovascular diseases, or respiratory disorders - Patients undergoing neurosurgery, cardiac surgery, or transplantation surgery - Patients scheduled for thoracotomy or laparotomy - Respiratory tract infection within the past month - Developmental disorders - Preoperative sedative administration - Patients for whom remimazolam administration is not recommended (remimazolam hypersensitivity, glaucoma, severe myasthenia gravis) - Other patients deemed unsuitable for participation in this study by the principal investigator or research collaborator

Design outcomes

Primary

MeasureTime frame
average blood pressure during surgery

Secondary

MeasureTime frame
intraoperative systolic blood pressure, incidence of hypotention, average heart rate during surgery, drug usage, Pediatric Anesthesia Emergence Delirium(PAED) score and incidence of emergence delirium within 20 minutes after extubation, time from anesthesia end to awaking, postoperative pain score, electroencephalography, the proportion of adverse events

Contacts

Public ContactSatoshi Kimura

Kyoto University Hospital

skimura@kuhp.kyoto-u.ac.jp+81-570-030-311

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026